Perrigo (NYSE:PRGO) Issues FY 2026 Earnings Guidance

26 Feb 2026, 19:00 by Sarita Garza · The Markets Daily

Perrigo (NYSE:PRGO – Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 2.250-2.550 for the period, compared to the consensus estimate of 2.700. The company issued revenue guidance of $4.0 billion-$4.2 billion, compared to the consensus revenue estimate of $4.2 billion.

Perrigo Stock Performance

PRGO traded down $0.50 during trading on Thursday, hitting $13.91. 3,902,717 shares of the company traded hands, compared to its average volume of 2,450,164. Perrigo has a one year low of $12.17 and a one year high of $30.93. The stock’s fifty day moving average is $14.39 and its 200 day moving average is $17.57. The company has a quick ratio of 1.44, a current ratio of 2.51 and a debt-to-equity ratio of 0.81. The firm has a market cap of $1.91 billion, a P/E ratio of -36.63, a price-to-earnings-growth ratio of 1.31 and a beta of 0.39.

Perrigo (NYSE:PRGO – Get Free Report) last released its earnings results on Thursday, February 26th. The company reported $0.77 earnings per share for the quarter, missing analysts’ consensus estimates of $0.80 by ($0.03). Perrigo had a negative net margin of 1.21% and a positive return on equity of 9.16%. The company had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.09 billion. During the same quarter in the previous year, the firm earned $0.93 earnings per share. The firm’s revenue was down 2.5% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, equities analysts predict that Perrigo will post 2.56 EPS for the current fiscal year.

Perrigo Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 24th. Shareholders of record on Monday, March 2nd will be given a dividend of $0.29 per share. The ex-dividend date is Monday, March 2nd. This represents a $1.16 annualized dividend and a dividend yield of 8.3%. Perrigo’s dividend payout ratio is currently -305.26%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on PRGO shares. Weiss Ratings reiterated a “sell (d+)” rating on shares of Perrigo in a research note on Monday, December 22nd. JPMorgan Chase & Co. cut their price objective on shares of Perrigo from $20.00 to $18.00 and set a “neutral” rating for the company in a research report on Monday, December 15th. Wall Street Zen cut shares of Perrigo from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Canaccord Genuity Group lowered their target price on shares of Perrigo from $40.00 to $20.00 and set a “buy” rating on the stock in a research note on Thursday, November 6th. Finally, Argus upgraded shares of Perrigo to a “hold” rating in a research report on Wednesday, January 14th. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $20.33.

Get Our Latest Analysis on PRGO

Institutional Investors Weigh In On Perrigo

A number of large investors have recently made changes to their positions in the business. Price T Rowe Associates Inc. MD grew its position in Perrigo by 3.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 17,574,227 shares of the company’s stock valued at $244,634,000 after buying an additional 653,925 shares during the period. Fuller & Thaler Asset Management Inc. boosted its position in shares of Perrigo by 291.9% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 7,824,759 shares of the company’s stock worth $108,921,000 after acquiring an additional 5,828,076 shares during the last quarter. State Street Corp grew its position in shares of Perrigo by 9.5% during the second quarter. State Street Corp now owns 7,340,323 shares of the company’s stock valued at $196,134,000 after purchasing an additional 637,678 shares in the last quarter. Invesco Ltd. grew its holdings in Perrigo by 134.2% during the 4th quarter. Invesco Ltd. now owns 4,542,415 shares of the company’s stock valued at $63,230,000 after buying an additional 2,602,724 shares in the last quarter. Finally, Ion Asset Management Ltd. increased its position in Perrigo by 34.7% in the second quarter. Ion Asset Management Ltd. now owns 3,817,621 shares of the company’s stock worth $102,007,000 after purchasing an additional 983,727 shares during the last quarter. 95.91% of the stock is currently owned by institutional investors.

About Perrigo

(Get Free Report)

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.